1. Background {#sec77998}
=============

Chronic kidney disease (CKD) and end-stage renal disease (ESRD) have become worldwide public health problems. The prevalence of ESRD is steadily rising in Iran. Its prevalence was 700000 in 2004 and its incidence rate was 173 per 100000 people in Iran ([@A23849R1]). Previous study has shown the prevalence and incidence of ESRD is increasing in Iran ([@A23849R2]). These conditions rise patient morbidity and mortality risks and impose a huge cost to the countries health system ([@A23849R3]). Hemodialysis (HD) is one of the lifesaving renal replacement therapies in patients with ESRD. There is a high prevalence of sleep disorders including sleep apnea syndrome, restless legs syndrome (RLS), sleep-disordered breathing, and excessive daytime sleepiness in patients on HD ([@A23849R4]). Different studies evaluated the effects of various factors such as laboratory, sociodemographic ([@A23849R5]), and health-related quality of life (HRQOL) ([@A23849R6]) on sleep quality (SQ) of patients on HD; however, the factors affecting SQ of patients on HD have not been recognized completely yet. In addition, some studies have shown poor SQ increases the risk of mortality in patients on HD ([@A23849R6], [@A23849R7]); hence, finding the risk factors of SQ might decrease mortality and morbidity of these patients.

2. Objectives {#sec77999}
=============

This study aimed to determine the prevalence of poor SQ and to identify its risk factors in patients on HD.

3. Patients and Methods {#sec78004}
=======================

3.1. Patients {#sec78000}
-------------

This cross-sectional multicenter study was conducted on 6979 patients on HD in 132 dialysis centers in Iran from October 2010 to August 2011. The following inclusion criteria were applied: age \> 13 years, individuals with stable clinical conditions, at least three-month history of HD, and receiving HD three times a week (each session lasting three to four hours). Patients with history of hospitalization for an acute illness, those with vascular access failure including those on dialysis via temporary central venous catheters, and those who refused to answer to the questionnaire were excluded from the study. The study protocol was approved by Ethics Committee of Baqiyatallah University of Medical Sciences, Tehran, Iran.

3.2. Instruments {#sec78001}
----------------

KDCS-SF version 1.3 questionnaire ([@A23849R8]) was used in this multicenter study. The KDCS-SF is a questionnaire to asses quality of life (QoL) and includes generic (SF-36) and disease-specific cores. The definition and exploration of the KDCS-SF and its components have been evaluated in previous study ([@A23849R9]) and the comprehensive translation and validation of SF-36 health survey have been explained in another study ([@A23849R10]). Sleep domain of disease-specific core of KDCS-SF questionnaire was used to assess patients' SQ. This domain contains four questions. In question No. 1 (Q~1~), patients were asked "on a scale from zero to ten, how would you rate your sleep overall?" Scores zero and ten correspond to very bad and very good SQ, respectively. In three other questions (Q~2~-Q~4~), patients were asked about the preceding four weeks: "How often have you been awaken during the night and had trouble falling asleep again?", "have you got the amount of the sleep you need?", and "have trouble staying awake during the day?" In these questions, patients choose one answer between these following responses: "never", "a few times", "sometimes", "a good bit of the time"," most of the time" and "always". In Q~1~, scores zero to ten converted to scores zero to 100 for analysis. Regarding Q~2~ and Q~4~, patients were scored zero when they chose "always" and 100 when chose "never" and 20, 40, 60, and 80 consecutively for choices between "always" and "never". In Q~3~, patients were scored 0, 20, 40, 60, 80, and 100 consecutively for choices from "never" through "always". Finally, we specified a total score of sleep component as SQ in analysis. Higher SQ score meant better quality of sleep. We categorized patients as good sleepers (SQ ≤ 61.2) and poor sleepers (SQ \> 61.2). To obtain this cutoff point, we statistically depicted receiver operating characteristic (ROC) curve using physical component summary (PCS; one of the two components of SF-36 questionnaire), because the association between PCS and SQ have been recognized previously ([@A23849R6]). As we searched, we found a study ([@A23849R11]) that had evaluated different cutoff points for PCS and finally, had chosen 60 as a cutoff score with 11.1 as likelihood ratio of positive test. Thus, using cutoff point of 60 for PCS, we drew ROC curve. After evaluating various cutoff points, we chose 61.2 as SQ cutoff point with 63.5% sensitivity and 67% specificity. Total SF-36 score was also considered as QoL. In addition, some of the symptoms from the symptoms/problems component of the questionnaire that were related to sleep were evaluated in this study as following: soreness in muscle, cramps, itchy skin, dry skin, and numbness in hands or feet. These symptoms were evaluated in the questionnaire by asking patients to answer one question concerning the extent of being bothered by mentioned symptoms during the preceding four weeks. Patients had to choose one of the following choices: "never", "somewhat bothered", "moderately bothered", "very much bothered" and "extremely bothered". These responses were scored consecutively as 100, 80, 60, 40, 20, and 0 for analysis. Two questions of questionnaire were used for hospital stay during the preceding six months: "Did you stay in any hospital overnight or longer?" and "Did you receive care at a hospital, but came home the same day?" Total days obtained from answers to these questions were considered as hospitalization days.

3.3. Data Collection {#sec78002}
--------------------

Sociodemographic and clinical data including age, sex, cause of dialysis such as diabetes mellitus (DM) or hypertension (HTN), work status (employed, unemployed, retired, housekeeper, or student), duration of dialysis, educational level, marital state, hemoglobin (Hb), ferritin, total iron binding capacity (TIBC), transferrin saturation (serum iron/TIBC, Fe/TIBC), calcium-phosphorus (Ca × P) product, parathyroid hormone (PTH) levels, serum uric acid, fasting blood sugar (FBS), serum albumin (Alb), triglyceride (TG), cholesterol (Chol), low-density lipoprotein (LDL), and high-density lipoprotein (HDL) were collected. Educational level was specified in four groups: uneducated, grade I (less than six years education), grade II (6 to 12 years education), and grade III (\> 12 years education). In addition, the Kt/V was used to evaluate adequacy of dialysis using 1 and 1.2 as cutoff point. The number of consumed drugs was defined as the number of drugs that patient had consumed for longer than one week.

3.4. Statistical Analysis {#sec78003}
-------------------------

Socio-economic and paraclinical variables and some of the components of the KDCS-SF questionnaire were evaluated and their associations with sleep component were analyzed. We used cutoff point of 10 and 11 g/dL (100 and 110 g/L) for Hb, 20% and 50% for Fe/TIBC, 100 ng/mL (224.20 pmol/L) for ferritin, 55 for Ca × P, 150 and 300 ng/L for PTH, 6 mg/dL (356.91 μmol/L) for uric acid, 126 mg/dL (6.99 mmol/L) for FBS, 40 g/L for albumin, 250 mg/dL (6.48 mmol/L) for Chol, 200 mg/dL (2.26 mmol/L) for TG, 70 mg/dL (1.81 mmol/L) for LDL, 40 mg/dL (1.04 mmol/L) for HDL, and 1 and 1.2 for Kt/V according to Handbook of Dialysis ([@A23849R12]). SPSS 20 for windows (IBM Inc., Somers, NY, USA) was used for statistical analysis. After univariate analysis using Chi square and Mann Whitney U tests, variables with P value \< 0.2 were entered to logistic regression model and Final model was obtained when all of P values were \< 0.1. A P value \< 0.05 was considered statistically significant. Moreover, Stata/SE version 11.2 (College Station, TX 77845, USA) was applied for linear regression analysis for hospital stay as an outcome.

4. Results {#sec78012}
==========

Among 6979 patients on HD, 6878 individuals (57% male and 43% female) completed the sleep component of questionnaire. Their ages ranged from 18 to 99 years, with a mean age of 54.4 ± 17.1 years. There was a higher proportion of older patients (\> 60 years old) in this study (39.7%); however, 28.6% of patients were younger than 46 years. The patients' sociodemographic and laboratory characteristics are shown in [Tables 1](#tbl19814){ref-type="table"} and [2](#tbl19815){ref-type="table"}. HTN was the most common underlying disease (32%) among the patients on HD, followed by DM (25.4%).

4.1. The Correlation of Socio-Demographic Characteristics and Quality of Sleep {#sec78005}
------------------------------------------------------------------------------

The mean SQ score was 55.9 ± 19.9. The majority of our patients had poor SQ (60.6%). Patients with DM were significantly more likely to have poor SQ (63.4%) in comparison to individuals with other underlying diseases. We found that female sex, DM, older age, widowhood, being housekeeper, being unemployed, longer duration of dialysis especially \> 10 years, and lower educational level had a significant correlation with poor SQ ([Table 1](#tbl19814){ref-type="table"}).

###### The Correlation of Socio-Demographic Factors With Sleep Quality ^[a](#fn17161){ref-type="table-fn"},[b](#fn17162){ref-type="table-fn"}^

                                              Sleep Quality   P Value       
  ------------------------------------------- --------------- ------------- -------
  **Cause of ESRD**                                                         0.004
  Unknown                                     703 (58.7)      494 (41.3)    
  DM                                          1066 (63.4)     616 (36.6)    
  HTN                                         1288 (61.4)     811 (38.6)    
  Other                                       927 (57.7)      680 (42.3)    
  Total^[c](#fn17163){ref-type="table-fn"}^   3984 (60.5)     2601 (39.5)   
  **Sex**                                                                   0.001
  Male                                        2281 (58.8)     1601 (41.2)   
  Female                                      1853 (62.9)     1094 (37.1)   
  Total^[c](#fn17163){ref-type="table-fn"}^   4134 (60.5)     2695 (39.5)   
  **Age, y**                                                                0.000
  ≤ 45                                        941 (50.2)      935 (49.8)    
  46-60                                       1272 (61.2)     807 (38.8)    
  \> 60                                       1735 (66.6)     871 (33.4)    
  Total^[c](#fn17163){ref-type="table-fn"}^   3948 (60.2)     2613 (39.8)   
  **Marital Status**                                                        0.000
  Single                                      384 (49.3)      395 (50.7)    
  Married                                     2976 (61.1)     1896 (38.9)   
  Widow/Widower                               697 (66.5)      351 (33.5)    
  Total^[c](#fn17163){ref-type="table-fn"}^   4057 (60.6)     2642 (39.4)   
  **Occupation Status**                                                     0.000
  Employed                                    305 (45.3)      369 (54.7)    
  Unemployed                                  1620 (62.0)     994 (38.0)    
  Retired                                     779 (62.1)      475 (37.9)    
  Housekeeper                                 1313 (62.8)     778 (37.2)    
  Student                                     25 (35.7)       45 (64.3)     
  Total^[c](#fn17163){ref-type="table-fn"}^   4042 (60.3)     2661 (39.7)   
  **Duration of Dialysis, mo**                                              0.000
  ≤ 12                                        1049 (55.6)     837 (44.4)    
  12.1-60                                     1971 (59.9)     1321 (40.1)   
  60.1-120                                    582 (68.0)      274 (32.0)    
  \> 120                                      170 (72.0)      66 (28.0)     
  Total^[c](#fn17163){ref-type="table-fn"}^   3772 (60.2)     2498 (39.8)   
  **Educational Level**                                                     0.000
  Uneducated                                  1718 (66.4)     871 (33.6)    
  Grade I                                     866 (59.0)      602 (41.0)    
  Grade II                                    608 (51.1)      581 (48.9)    
  Grade III                                   85 (42.3)       116 (57.7)    
  Total^[c](#fn17163){ref-type="table-fn"}^   3277 (60.2)     2170 (39.8)   

^a^ Abbreviations: ESRD, end-stage renal disease; DM, diabetes mellitus; and HTN, hypertension.

^b^ Data are presented as No. (%).

^c^ Missing data is the reason of different total numbers.

###### The Correlation Between Laboratory Data and Quality of Sleep ^[a](#fn17164){ref-type="table-fn"},[b](#fn17165){ref-type="table-fn"}^

                                              Sleep Quality   P Value       
  ------------------------------------------- --------------- ------------- -------
  **Hb, g/dL**                                                              0.1
  \< 10                                       1630 (63.7)     930 (36.3)    
  10-11                                       774 (58.5)      548 (41.5)    
  \> 11                                       1131 (61.8)     698 (38.2)    
  Total^[c](#fn17166){ref-type="table-fn"}^   3535 (61.9)     2176 (38.1)   
  **Fe/TIBC, %**                                                            0.5
  ≤ 20                                        212 (57.0)      160 (43.0)    
  \> 20, ≤ 50                                 298 (57.9)      217 (42.1)    
  \> 50                                       61 (61.6)       38 (38.4)     
  Total^[c](#fn17166){ref-type="table-fn"}^   571 (57.9)      415 (42.1)    
  **Ferritin, ng/mL**                                                       0.2
  ≤ 100                                       92 (56.1)       72 (43.9)     
  \> 100                                      968 (61.1)      617 (38.9)    
  Total^[c](#fn17166){ref-type="table-fn"}^   1060 (60.6)     689 (39.4)    
  **Ca** **×** **P**                                                        0.5
  \< 55                                       2301 (61.3)     1454 (38.7)   
  ≥ 55                                        1117 (62.3)     677 (37.7)    
  Total^[c](#fn17166){ref-type="table-fn"}^   3418 (61.6)     2131 (38.4)   
  **PTH, pg/mL**                                                            0.7
  ≤ 150                                       141 (65.0)      76 (35.0)     
  150-300                                     92 (57.5)       68 (42.5)     
  ≥ 300                                       192 (62.7)      114 (37.3)    
  Total^[c](#fn17166){ref-type="table-fn"}^   425 (62.2)      258 (37.8)    
  **Uric acid, mg/dL**                                                      0.9
  ≤ 6                                         414 (57.1)      311 (42.9)    
  \> 6                                        927 (57.3)      692 (42.7)    
  Total^[c](#fn17166){ref-type="table-fn"}^   1341 (57.2)     1003 (42.8)   
  **FBS, mg/dL**                                                            0.002
  ≤ 126                                       1377 (56.7)     1053 (43.3)   
  \> 126                                      800 (62.0)      491 (38.0)    
  Total^[c](#fn17166){ref-type="table-fn"}^   2177 (58.5)     1544 (41.5)   
  **Alb, g/dL**                                                             0.05
  ≤ 4                                         840 (62.1)      512 (37.9)    
  \> 4                                        1291 (58.8)     905 (41.2)    
  Total^[c](#fn17166){ref-type="table-fn"}^   2131 (60.1)     1417 (39.9)   
  **Chol, mg/dL**                                                           0.9
  ≤ 250                                       2579 (60.1)     1710 (39.9)   
  \> 250                                      89 (59.7)       60 (40.3)     
  Total^[c](#fn17166){ref-type="table-fn"}^   2668 (60.1)     1770 (39.9)   
  **TG, mg/dL**                                                             0.4
  ≤ 200                                       1975 (59.8)     1328 (40.2)   
  \> 200                                      592 (61.3)      374 (38.7)    
  Total^[c](#fn17166){ref-type="table-fn"}^   2567 (60.1)     1702 (39.9)   
  **LDL, mg/dL**                                                            0.4
  ≤ 70                                        142 (62.8)      84 (37.2)     
  \> 70                                       273 (66.3)      139 (33.7)    
  Total^[c](#fn17166){ref-type="table-fn"}^   415 (65.0)      223 (35.0)    
  **HDL, mg/dL**                                                            0.5
  ≤ 40                                        251 (64.4)      139 (35.6)    
  \> 40                                       173 (67.1)      85 (32.9)     
  Total^[c](#fn17166){ref-type="table-fn"}^   424 (65.4)      224 (34.6)    
  **Kt/V**                                                                  0.9
  \< 1                                        1079 (59.4)     739 (40.6)    
  ≥ 1, ≤ 1.2                                  434 (56.3)      337 (43.7)    
  \> 1.2                                      254 (61.1)      162 (38.9)    
  Total^[c](#fn17166){ref-type="table-fn"}^   1767 (58.8)     1238 (41.2)   

^a^ Abbreviations: Hb, hemoglobin;Fe\\TIBC, transferrin saturation; Ca × P, calcium-phosphorus product; PTH, parathyroid hormone; FBS, fasting blood sugar; Alb, albumin; Chol, cholesterol; TG, triglyceride; LDL, low-density lipoprotein; and HDL, high-density lipoprotein.

^b^ Data are presented as No. (%).

^c^ Missing data is the reason of different total numbers.

4.2. The Correlation of Laboratory Variables and Quality of Sleep {#sec78006}
-----------------------------------------------------------------

There was no significant difference between serum Hb, ferritin, PTH, Ca × P, uric acid, Alb, Kt/V, and lipid profile (Chol, TG, LDL, and HDL) between poor sleeper and good sleeper ([Table 2](#tbl19815){ref-type="table"}). FBS \> 126 mg/dL (6.99 mmol/L) was the only variable that increased the risk of poor sleep (P = 0.002) so that 62% of patients with DM were poor sleeper while only 56.7% of patients with FBS ≤ 126 mg/dL (≤ 6.99 mmol/L) had poor SQ. We also detected a U-shape correlation between Kt/V and SQ; patients with Kt/V between 1 and 1.2 were more likely to have good sleep; however, this correlation was not significant.

4.3. The Correlation of Clinical Symptoms and Quality of Sleep {#sec78007}
--------------------------------------------------------------

A significant association was seen between muscle soreness, cramps, itchy skin, dry skin, and numbness in extremities with SQ (P ≤ 0.001). [Table 3](#tbl19816){ref-type="table"} shows the number and percentage of individual's response about the extent of being bordered by these symptoms that had led to poor SQ, from "not at all" to "extremely". Although each one of these symptoms were a risk factor of poor SQ, the percentage of poor SQ among individual's that were extremely bothered by muscle soreness was higher (81.4%) in comparison to other symptoms.

###### Univariate Association Between Clinical Symptoms and Quality of Sleep ^[a](#fn17167){ref-type="table-fn"}^

                                              Sleep Quality   P Value       
  ------------------------------------------- --------------- ------------- ---------
  **Muscle soreness**                                                       ≤ 0.001
  Extremely                                   665 (81.4)      152 (18.6)    
  Very Much                                   1085 (70.2)     461 (29.8)    
  Moderately                                  869 (64.0)      488 (36.0)    
  Somewhat                                    930 (56.7)      711 (43.3)    
  Not at All                                  553 (39.2)      858 (60.8)    
  Total^[b](#fn17168){ref-type="table-fn"}^   4102 (60.6)     2670 (39.4)   
  **Cramps**                                                                ≤ 0.001
  Extremely                                   553 (78.1)      155 (21.9)    
  Very Much                                   870 (73.9)      308 (26.1)    
  Moderately                                  985 (64.3)      547 (35.7)    
  Somewhat                                    939 (55.3)      759 (44.7)    
  Not at All                                  721 (45.0)      880 (55.0)    
  Total^[b](#fn17168){ref-type="table-fn"}^   4068 (60.6)     2649 (39.4)   
  **Itchy Skin**                                                            ≤ 0.001
  Extremely                                   442 (69.7)      192 (30.3)    
  Very Much                                   713 (72.9)      265 (27.1)    
  Moderately                                  812 (65.5)      428 (34.5)    
  Somewhat                                    896 (59.7)      605 (40.3)    
  Not at All                                  1223 (51.2)     1165 (48.8)   
  Total^[b](#fn17168){ref-type="table-fn"}^   4086 (60.6)     2655 (39.4)   
  **Dry Skin**                                                              ≤ 0.001
  Extremely                                   292 (74.3)      101 (25.7)    
  Very Much                                   726 (75.1)      241 (24.9)    
  Moderately                                  800 (69.5)      351 (30.5)    
  Somewhat                                    951 (62.4)      573 (37.6)    
  Not at All                                  1271 (48.6)     1345 (51.4)   
  Total^[b](#fn17168){ref-type="table-fn"}^   4040 (60.7)     2611 (39.3)   
  **Numbness in Extremities**                                               ≤ 0.001
  Extremely                                   317 (79.1)      84 (20.9)     
  Very Much                                   653 (75.1)      216 (24.9)    
  Moderately                                  932 (69.9)      401 (30.1)    
  Somewhat                                    1046 (61.1)     665 (38.9)    
  Not at All                                  932 (44.2)      1176 (55.8)   
  Total^[b](#fn17168){ref-type="table-fn"}^   3880 (60.4)     2542 (39.6)   

^a^Data are presented as No. (%).

^b^Missing data is the reason of different total numbers.

4.4. The Correlation Between Hospital Stay, Number of Patient's Drug Consumption, and Quality of Sleep {#sec78008}
------------------------------------------------------------------------------------------------------

The mean of hospital stay was 6.3 ± 12.9 days (range, 0-105). The mean of hospital stay among patient with poor sleep was significantly higher (P ≤ 0.001) than among those with good sleep (6.8 vs. 5.4 days). Furthermore, patients with poor SQ were prescribed a greater number of medications when compared to individuals with good SQ (average number of drugs, 4.8 vs. 4.2; P ≤ 0.001).

4.5. The Correlation of Quality of Life Components and Quality of Sleep {#sec78009}
-----------------------------------------------------------------------

The association between some components of KDCS-SF questionnaire including cognitive function, sexual function, social support, and patient satisfaction were analyzed with SQ. All of these components had a significant association with SQ (P ≤ 0.001). This means lower score of each component, which shows worse situation in the component, would increase the chance of poor SQ. In addition, total SF-36 score was also associated with SQ; in other words, the lower the score of QoL was, the worse the SQ would be (P ≤ 0.001).

4.6. Multivariate Logistic Regression; Effect of Factors on Quality of Sleep {#sec78010}
----------------------------------------------------------------------------

After adjustment for covariates including causes of ESRD, sex, age, marital status, job status, dialysis duration, FBS, Alb, muscle soreness, cramps, itchy skin, dry skin, numbness in extremities, total SF-36 score, hospital stay, social support, cognitive function, patient satisfaction, and educational level, only younger age (\< 45 years old; OR = 1.54), shorter dialysis vintage (≤ 60 months), less muscle cramp, high QoL, high cognitive function score, and high sexual function had significant correlation with good SQ ([Table 4](#tbl19817){ref-type="table"}).

###### Logistic Regression Analysis Based on Factors Contributing to Sleep Quality in the Patients on Hemodialysis ^[a](#fn17169){ref-type="table-fn"}^

                                 P value    OR      SE (OR)   95% CI
  ------------------------------ ---------- ------- --------- ---------------
  **Age, y**                                                  
  ≤ 45                           0.005      1.540   0.237     (1.140-2.081)
  46-60                          0.248      1.191   0.179     (0.886-1.601)
  \> 60                          baseline                     
  **Duration of Dialysis, mo**                                
  ≤ 12                           0.027      2.168   0.760     (1.090-4.311)
  12.1-60                        0.029      2.116   0\. 727   (1.078-4.154)
  60.1-120                       0.646      1.187   0.442     (0.571-2.468)
  \> 120                         Baseline                     
  **Less Muscle Cramps**         0.001      1.006   0.002     (1.002-1.010)
  **SF-36 Score**                ≤ 0.001    1.031   0.004     (1.023-1.039)
  **Cognitive Function**         0.001      1.011   0.003     (1.004-1.017)
  **Sexual Function**            0.017      1.005   0.002     (1.001-1.009)

^a^ Abbreviations: OR, odds ratio; SE, standard error; and CI, confidence interval.

4.7. Hospital Stay as an Outcome {#sec78011}
--------------------------------

We evaluated the association between SQ, QoL, and hospital stay. After adjusting for sociodemographic and basic characteristics including age, sex, occupational status, marital state, educational level, duration of dialysis, and cause of ESRD in multivariate linear regression, we found a significant association among SQ (B = -1.307, P = 0.001), QoL (B = -0.043, P ≤ 0.001), and hospital stay.

5. Discussion {#sec78013}
=============

In the current study with a large number of patients, we found a new cutoff point for classification of SQ subscale of KDCS-SF questionnaire, which was used to assess the SQ by several studies ([@A23849R6], [@A23849R7], [@A23849R13]-[@A23849R15]). For example, Elder et al. ([@A23849R6]) and Brekke et al. ([@A23849R7]) applied Q~1~ in sleep component of KDCS-SF questionnaire to assess self-reported SQ in patients on dialysis using 60 and 50 as cutoff points. Although some studies ([@A23849R13], [@A23849R14]) used the same instrument of the present study, they did not specify any cutoff points. To our knowledge, only one study ([@A23849R15]), applied sleep subscale of KDCS-SF questionnaire and classified SQ in cutoff point of 60 using self-reported SQ in CKD. In the present study, we found 61.2 as a cutoff point with good values for sensitivity and specificity. Applying this cutoff point, 60.6% of our patients had poor SQ, which was consistent with findings in other studies ([@A23849R4], [@A23849R16], [@A23849R17]). The prevalence of poor SQ among patients on HD ranges from 41% to 86% ([@A23849R4], [@A23849R16], [@A23849R17]), while its prevalence in general population is less than 40% (range, 7%-40%) ([@A23849R18]-[@A23849R20]). In a study, insomnia symptoms occurred in 36.2% of general population ([@A23849R20]); in addition, another investigation reported that 20.1% of general population had sleep difficulty ([@A23849R19]). Thus, patients on HD have a high prevalence of sleep disorders and such studies that aim to find factors affecting SQ are important. Some studies showed QoL as a predictor for the length of hospital stay in patients on HD ([@A23849R9], [@A23849R21]). For example, Rostami et al. ([@A23849R9]) reported an inverse association between HRQOL and hospital stay. Our study also demonstrated a negative correlation among SQ, QoL, and hospitalization even after adjusting for sociodemographic factors. The higher the SQ score was, the fewer the hospitalization days would be; ie, one point increase in SQ score would lead to 1.3 days decrease in hospital stay. It is obvious that improving of SQ and QoL in patients on HD would result in declining of costs too. In the present study, HTN and DM were most prevalent causes of ESRD. However, most studies reported DM as the most common cause of ESRD, followed by HTN ([@A23849R22], [@A23849R23]). Nevertheless, in some races and regions, HTN has been reported as the most common cause of ESRD ([@A23849R24], [@A23849R25]). The third common cause of ESRD was "unknown", which was similar to the reports by other studies ([@A23849R22], [@A23849R23]). Many patients were referred with advanced renal failure and their kidneys were shrunk in ultrasonography. Therefore, they did not need renal biopsy to confirm the diagnosis. In addition, patients with advanced age had higher chances of experiencing poor SQ. We found that a good SQ was significantly prevalent in patients younger than 45 years of age in comparison to older patients. Moreover, most investigators have revealed the association between age and SQ ([@A23849R5], [@A23849R26]). For example, in a study on 61 Patients on HD, Sabet et al. showed that younger patients had better SQ than older individuals did ([@A23849R5]). Yoshioka et al. also found that SQ was reduced by aging ([@A23849R26]). This finding might be partly due to bad nutritional status and less physical activity in elderly patients. The sex of the patients had no affect SQ in our study, which was consistent with other studies ([@A23849R27], [@A23849R28]). Nevertheless, few studies reported that poor SQ was significantly different between sexes ([@A23849R5], [@A23849R29]). In a series of 61 patients on HD, women had lower SQ in comparison to men ([@A23849R5]). It was also demonstrated that in patients on HD, sleep apnea syndrome was frequently occurred in males ([@A23849R30]) while RLS was more common in females ([@A23849R31]) However, there were no differences in SQ between males and females in the present study. In several studies, the association between components of SF-36 questionnaire (PCS and MCS \[Mental Component Summary\]) with SQ has been evaluated ([@A23849R6], [@A23849R32]). In this study, we used total SF-36 score as QoL score and found a significant positive correlation between QoL and SQ. It means that patients with lower QoL score were more likely to have poor SQ. In addition, we found a significant association between SQ and all domains of SF-36 questionnaire including role-physical, bodily pain, general health, vitality (energy/fatigue), social functioning, mental health (emotional well-being), and role-emotion, which was consistent with findings of other studies ([@A23849R6], [@A23849R16]). Iliescu et al. found that both PCS and MCS score had correlation with good SQ, even after controlling different confounders ([@A23849R16]). However, Edalat-Nejad et al. ([@A23849R33]) did not found any correlation between PCS and SQ, and conversely, Sathvik et al. ([@A23849R34]) reported no association between MCS and SQ. There is a controversy over the role of Kt/V as dialysis adequacy. For example, iliescu et al. mentioned no association between Kt/V and SQ ([@A23849R16]). Bastos et al. conducted a study on 100 patients on HD and revealed that individuals with excessive daytime sleepiness had lower score of the Kt/V index ([@A23849R27]). Moreover, Mucsi et al. evaluated the association of RLS with age, sex, presence of DM, Kt/V, number of comorbid condition, and PTH levels in logistic regression analysis and found only Kt/V \< 1.2 had significant association with RLS ([@A23849R35]). Although we detected a U-shape correlation between Kt/V and SQ, this correlation was not significant in both univariate and multivariate analyses, which was consistent with findings of other studies ([@A23849R16], [@A23849R32]). Kt/V might not be a perfect index to assess dialysis adequacy or dialysis frequency would more significantly affect the SQ than dialysis quality would; therefore, we suggest a study to evaluate the role of dialysis frequency in SQ of patients on HD. There were significant differences between patients with duration of dialysis \< 60 months and \> 10 years in the present study. Patients with duration of dialysis shorter than 60 months had significantly better SQ in comparison to other individuals. Sabet et al. ([@A23849R5]) showed that as duration of HD increased, the SQ would decrease. Sabbatini et al. ([@A23849R36]) also conducted a study on 311 patients on HD and showed a significant association between insomnia and duration of dialysis \> 12 months. It would be due to the overlap of diseases and symptomssuch as neurologic and cardiovascular disease that usually develop in patients who were on HD for a long time or renal osteodystrophy, which leads to bone pain and/or pruritus, which progress with time and can affect patients SQ. Several sleep-related sexual disorders such as sleep exacerbation of persistent sexual arousal syndrome and sleep-related painful erections have been expressed in general population ([@A23849R37]). Nevertheless, to our knowledge, evaluating the influence of sexual dysfunction on SQ in patients on HD had not been done before. However, Robinson et al. ([@A23849R38]) showed a strong association between sexual activity and QoL in older adults. Our study showed a positive correlation between sexual function and SQ in patients on HD. In other words, as score of sexual function component of KDQL questionnaire increased, SQ would increase.

Our study had some limitations due to its cross-sectional nature. First, we could not suggest a cause-and-effect relationship while we could show associations between study variables. Second, since we did not follow our patients, their mortality rate remained unrevealed. Thus, we could not evaluate association among SQ, QoL, and mortality. Third, we assessed quality of sleep overly by means of a component of KDQL questionnaire; therefore, we did not have any data about type of individuals' sleep disorders. With improving some amendable factors and QoL of patients on HD, we can promote their SQ that might lead to reduction in length of hospital stay. In addition, we found that age and dialysis duration had negative association with SQ. Since these are non-modifiable factors, earlier renal transplantation for patients on HD would help them. However, other studies need to evaluate and compare SQ between patients on HD and transplant patients.
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